Inflammatory factors and immunoglobulins alterations in subjects with type 2 diabetes mellitus treated with squalene

Authors

  • Danik Martirosyan PhD, Functional Food Center/Functional Food Institute
  • Mohammad Reza Ashoori Department of Laboratory Sciences, School of Allied Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran
  • Afsaneh Seyed Mikaeili Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Islamic Azad University, Pharmaceutical Sciences Branch, Tehran, Iran
  • Shaghayegh Pezeshki PhD, Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Anna Serani Georgia Institute of Technology, Atlanta, Georgia, USA
  • Michelle Lee Cornell University, Ithaca, New York, USA
  • Hossein Mirmiranpour Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.31989/ffs.v2i8.979

Abstract

Background: Squalene is a 30-carbon (as a polyunsaturated triterpene) compound that has been suggested to have several benefits. In recent years, its anti-diabetic, anti-inflammatory and antioxidant effects have been studied.

Objective: The aim of this study was to investigate the effect of different doses of squalene on different days on the changes in the levels of inflammatory cytokines and antibodies in people with type 2 diabetes and then compare it.

Methods: In this study, 4 groups with type 2 diabetes mellitus and 1 control group were selected. 4 groups with type 2 diabetes mellitus were divided into 1 diabetic group without squalene consumption for 84 days and 3 diabetic groups treated with squalene in doses of 200, 400 and 600 mg, respectively for 84 days. The levels of Interleukin-1 alpha, Interleukin-1 beta, Interleukin-4, immunoglobulin A, immunoglobulin G, immunoglobulin M, and as well as the glucose of all participants were measured by Enzyme-linked immunosorbent assay method. 

Results: On days 14 and 28, a statistically significant difference (P value < 0.05) was observed in the level of Interleukin-1 alpha and Interleukin-4 in groups 3, 4 and 5 compared to group 2. This significant difference in the levels of interleukin-1 beta and immunoglobulin A was observed only on days 56 and 84. No statistically significant difference (P value > 0.05) was observed in the levels of immunoglobulins G, M, and glucose during the consumption of squalene between the groups.

Conclusions: According to the time and dose, squalene can be effective in reducing inflammatory factors and increasing immunoglobulin A. However, additional studies are needed for the action mechanism and the effect of squalene.

Keywords: squalene, triterpene, interleukin, immunoglobulin, diabetes mellitus

Downloads

Published

2022-08-30

Issue

Vol. 2 No. 8 (2022): August 2022

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.